par 545 Pill - yellow oval, 14mm
Pill with imprint par 545 is Yellow, Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Par Pharmaceutical Inc.
Ranitidine is used in the treatment of GERD; Cutaneous Mastocytosis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Erosive Esophagitis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 545
Ranitidine Hydrochloride
- Imprint
- par 545
- Strength
- 300 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc.
- National Drug Code (NDC)
- 49884-0545 (Discontinued)
- Inactive Ingredients
-
FD&C Yellow No. 6,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
titanium dioxide,
triethyl citrate,
ferric oxide yellow,
corn starch
Note: Inactive ingredients may vary.
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
- Ranitidine drug information
- Ranitidine Tablets and Capsules
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
